Assembly Biosciences (ASMB) Receivables - Net (2017 - 2026)

Assembly Biosciences' Receivables - Net history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $451000.0 in Q1 2026; TTM through Mar 2026 was $451000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $974000.0, changed N/A from the prior year.
• Receivables - Net slipped to $451000.0 in Q1 2026 per ASMB's latest filing, from $974000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $1.2 million in Q3 2022 and bottomed at $43000.0 in Q4 2023.
• The 5-year median for Receivables - Net is $524000.0 (2022), against an average of $610818.2.
• Across the five-year window, Receivables - Net soared 180.95% in 2022 and plunged 95.44% in 2023, its largest moves.
• Year by year, Receivables - Net stood at $944000.0 in 2022, then plunged by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then soared by 2165.12% to $974000.0 in 2025, then slumped by 53.7% to $451000.0 in 2026.
• Per Business Quant, the three latest ASMB Receivables - Net figures stand at $451000.0 (Q1 2026), $974000.0 (Q4 2025), and $912000.0 (Q3 2025).